Pharmacological Profile and Indications of Non-Vitamin K Antagonist Oral Anticoagulants: Updated Review | Chapter 06 | Modern Advances in Pharmaceutical Research Vol. 2
The non-vitamin K antagonist oral
anticoagulants have been approved since 2008 for the prevention of systemic
embolism and stroke in patients with non-valvular atrial fibrillation with
prior stroke, transient ischemic attack, or CHA2DS2-VASc
score ≥2. According to the latest guidelines, if CHA2DS2-VASc
score ≥2 for all male patients or if CHA2DS2-VASc score
≥3 for all female patients, oral anticoagulants are recommended, and
considering shared decision between doctor and patient. However, they are
contraindicated in patients with mechanical prosthetic valve and in patients
with moderate-to-severe mitral stenosis and atrial fibrillation. They have also
been approved for prevention and treatment of deep vein thrombosis and
pulmonary embolism. Dabigatran, a direct thrombin inhibitor, was the first to
be approved, followed by the factor Xa inhibitors, rivaroxaban, apixaban, and
in 2015, edoxaban. They have advantages such as the use of fixed-dose, with
infrequent drug interaction, rapid onset of action and do not require
monitoring of their anticoagulant action. Nonetheless, they have different
half-lives, the need for dose adjustment according to renal function, weight
and age of the patient. Its use in pregnant women and children or adolescents
is not well established. There are also peculiarities about the risks of
bleeding, effects on coagulation tests and specific antidotes. Through this
review we discuss the pharmacokinetics and pharmacodynamics characteristics of
direct oral anticoagulants, its indications, interactions and
contraindications. Analysis of its efficacy, safety, risk-benefit ratio and
costs will also be addressed.
Author(s) Details
Rose Mary Ferreira Lisboa
da Silva
Department of Internal
Medicine, Faculty of Medicine, Federal University of Minas Gerais, Brazil.
View Volume: https://doi.org/10.9734/bpi/mapr/v2
Comments
Post a Comment